Article ID Journal Published Year Pages File Type
8777891 European Journal of Obstetrics & Gynecology and Reproductive Biology 2018 7 Pages PDF
Abstract
Secondary cytoreductive surgery is acceptable as a viable treatment option for highly selected women with ovarian cancer recurrence. Complete resection is considered ultimate goal of secondary cytoreduction on condition that the balance between maximal survival gain and minimal operative morbidity will be kept.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer
Authors
, , , , , ,